Strasbourg adrenal cancer patient study
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at patients with adrenal cortex carcinoma who were treated at Strasbourg University Hospital. It aims to better understand the condition and its outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with adrenal cortex carcinoma
- You received care at Strasbourg University Hospital between January 2000 and May 2025
- Your tumor was confirmed to be adrenal cortex carcinoma by tissue review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information from people diagnosed with adrenocortical carcinoma (a rare cancer of the adrenal gland). It can help doctors understand the disease and improve future care by tracking outcomes and treatments.
This study looks at adrenal tumors found on imaging (scans) to better understand what causes them and how they might be treated. If you have an adrenal tumor on a scan, this trial may be looking to enroll you for that purpose.
This study looks back at medical records to find out what factors helped people with advanced melanoma respond completely to immunotherapy. It includes patients treated at a specific hospital in France between 2013 and 2021.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This study looks at how the adrenal glands recover after children with leukemia or lymphoma are treated with steroids. The goal is to see how common adrenal suppression is and to help doctors monitor this safely.
This study is building a medical database for people with adrenal gland problems like Cushing's syndrome or adrenal tumors. It may help doctors understand these conditions better and improve future care.
Hear when a new Adrenal Cortical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.